目的探析小儿哮喘应用布地奈德联合硫酸沙丁胺醇雾化吸入方案治疗的临床效果。方法一般资料来自本院2015年-2016年儿科收治确诊哮喘患儿相关临床数据,在该群体中抽取262例以随机数字表方式将其分为对照组(单纯布地奈德雾化吸入手段治疗)、观察组(布地奈德联合硫酸沙丁胺醇雾化吸入治疗),各组131例。比较不同干预手段对患儿哮喘病情控制改善作用。结果根据患儿症状改善作为疗效评估标准,对症组与观察组判定无效患儿例数分别为24例、3例,组间总有效率经计算与统计学软件处理表示有意义(P<0.05);随访期间对照组、观察组出现治疗引发相关不良反应例数分别为18例、2例,发生率统计学软件处理表示有意义(P<0.05)。结论对哮喘患儿制定布地奈德联合硫酸沙丁胺醇雾化吸入治疗手段对病情有改善作用,不仅疗效突出且安全性较高,值得临床推广。 Objective To investigate the clinical effect of budesonide combined with salbutamol sulfate nebulization in pediatric asthma. Methods General information was collected from the clinical data of pediatric patients diagnosed with asthma from 2015 to 2016 in our hospital. A total of 262 patients were randomly divided into control group (budesonide inhalation therapy) , Observation group (budesonide combined with salbutamol sulfate inhalation therapy), 131 cases in each group. Comparison of different interventions in children with asthma control to improve the role. Results According to the symptom improvement of children as the evaluation standard of curative effect, the number of children who were judged to be invalid in the symptomatic group and the observation group were 24 cases and 3 cases, respectively. The total effective rate was statistically significant (P <0.05) There were 18 cases in the control group and 2 cases in the observation group during the follow-up period, respectively. The incidence of adverse events was statistically significant (P <0.05). Conclusions The preparation of budesonide combined with salbutamol sulfate atomization inhalation therapy in children with asthma has an improving effect on the disease, which not only has obvious curative effect but also high safety, which is worthy of clinical promotion.